Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

114 trials with published results (38%)

Research Maturity

206 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 27/100

Termination Rate

5.4%

16 terminated out of 299 trials

Success Rate

92.8%

+6.3% vs benchmark

Late-Stage Pipeline

13%

40 trials in Phase 3/4

Results Transparency

55%

114 of 206 completed with results

Key Signals

114 with results93% success16 terminated

Data Visualizations

Phase Distribution

250Total
Not Applicable (184)
Early P 1 (1)
P 1 (7)
P 2 (18)
P 3 (29)
P 4 (11)

Trial Status

Completed206
Unknown33
Terminated16
Not Yet Recruiting13
Recruiting13
Withdrawn8

Trial Success Rate

92.8%

Benchmark: 86.5%

Based on 206 completed trials

Clinical Trials (299)

Showing 20 of 20 trials
NCT07570602Not ApplicableCompletedPrimary

VisionApp - Refraction and Presbyopia

NCT07559188Not ApplicableNot Yet Recruiting

Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus

NCT07161635Not ApplicableActive Not Recruiting

Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs

NCT07076160Not ApplicableCompleted

Pilot Dispensing Study of Two Marketed Daily Disposable Multifocal Contact Lenses

NCT06869044Not ApplicableCompleted

A Clinical Comparison of Proclear® 1 Day Multifocal and Clariti® 1 Day Multifocal 3 Add

NCT07444658Not ApplicableRecruitingPrimary

Performance of Two Daily Disposable Multifocal Contact Lenses

NCT04774237Phase 2CompletedPrimary

Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic Presbyopia

NCT07151612Phase 4CompletedPrimary

The Development of New Functions of Esculin and Digitalis Glycosides Eye Drops: A Study on the Treatment of Presbyopia

NCT06166901Not ApplicableCompleted

Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)

NCT07484191Not ApplicableNot Yet Recruiting

Contralateral Claims Study of Clareon Vivity Pro

NCT03499821Not ApplicableCompletedPrimary

Clinical Performance of a Phakic Intraocular Lens (IOL)

NCT05646719Phase 3CompletedPrimary

Safety and Efficacy of Nyxol Eye Drops as a Single Agent and With Adjunctive Low-Dose Pilocarpine Eye Drops in Subjects With Presbyopia

NCT06542497Phase 3CompletedPrimary

Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia

NCT05510687Not ApplicableActive Not RecruitingPrimary

Transforming Households With Refraction and Innovative Financial Technology

NCT07439835CompletedPrimary

Evaluation of the Visual Acuity Curves of an Enhanced Monofocal Intraocular Lens

NCT07218731Not ApplicableRecruiting

Presbyopic Wear Experience With Multifocal Lenses Compared to Single Vision Lenses and Reading Glasses

NCT05728944Phase 3CompletedPrimary

Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT05656027Phase 3CompletedPrimary

Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of Presbyopia

NCT06460389CompletedPrimary

Visual Outcomes After Extended Depth of Focus Intraocular Lens Implantation With and Without Digital Assistance

NCT05411341Completed

Comparison of Two Different Optical Biometric Systems

Scroll to load more

Research Network

Activity Timeline